What is a stock summary page? Click here for an overview.
Business Description
Sight Sciences Inc
NAICS : 423450
SIC : 5047
ISIN : US82657M1053
Description
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.98 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.46 | |||||
| Debt-to-EBITDA | -0.88 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -1.06 | |||||
| Beneish M-Score | -3.98 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -4.5 | |||||
| 3-Year EBITDA Growth Rate | 24.9 | |||||
| 3-Year EPS without NRI Growth Rate | 22.3 | |||||
| 3-Year FCF Growth Rate | 39 | |||||
| 3-Year Book Growth Rate | -29.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 13.38 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 5.16 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.91 | |||||
| 9-Day RSI | 65.53 | |||||
| 14-Day RSI | 61.94 | |||||
| 3-1 Month Momentum % | -18.53 | |||||
| 6-1 Month Momentum % | -52.69 | |||||
| 12-1 Month Momentum % | -51.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.04 | |||||
| Quick Ratio | 8.63 | |||||
| Cash Ratio | 7.78 | |||||
| Days Inventory | 213.79 | |||||
| Days Sales Outstanding | 67.24 | |||||
| Days Payable | 52.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.4 | |||||
| Shareholder Yield % | -0.89 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 85.5 | |||||
| Operating Margin % | -63.27 | |||||
| Net Margin % | -64.49 | |||||
| FCF Margin % | -28.47 | |||||
| ROE % | -50.15 | |||||
| ROA % | -33.96 | |||||
| ROIC % | -240.06 | |||||
| 3-Year ROIIC % | 18.33 | |||||
| ROC (Joel Greenblatt) % | -327.61 | |||||
| ROCE % | -33.68 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.93 | |||||
| PB Ratio | 1.8 | |||||
| Price-to-Tangible-Book | 1.8 | |||||
| EV-to-EBIT | -1.86 | |||||
| EV-to-Forward-EBIT | -2 | |||||
| EV-to-EBITDA | -1.88 | |||||
| EV-to-Forward-EBITDA | -2.03 | |||||
| EV-to-Revenue | 1.08 | |||||
| EV-to-Forward-Revenue | 1.15 | |||||
| EV-to-FCF | -3.8 | |||||
| Price-to-GF-Value | 0.43 | |||||
| Price-to-Net-Current-Asset-Value | 1.86 | |||||
| Price-to-Net-Cash | 2.41 | |||||
| Earnings Yield (Greenblatt) % | -53.76 | |||||
| FCF Yield % | -14.23 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SGHT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sight Sciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 79.866 | ||
| EPS (TTM) ($) | -1.03 | ||
| Beta | 2.76 | ||
| 3-Year Sharpe Ratio | -0.08 | ||
| 3-Year Sortino Ratio | -0.14 | ||
| Volatility % | 47.34 | ||
| 14-Day RSI | 61.94 | ||
| 14-Day ATR ($) | 0.264041 | ||
| 20-Day SMA ($) | 2.576 | ||
| 12-1 Month Momentum % | -51.7 | ||
| 52-Week Range ($) | 2.03 - 8.45 | ||
| Shares Outstanding (Mil) | 51.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sight Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sight Sciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sight Sciences Inc Frequently Asked Questions
What is Sight Sciences Inc(SGHT)'s stock price today?
The current price of SGHT is $3.09. The 52 week high of SGHT is $8.45 and 52 week low is $2.03.
When is next earnings date of Sight Sciences Inc(SGHT)?
The next earnings date of Sight Sciences Inc(SGHT) is 2025-05-02 Est..
Does Sight Sciences Inc(SGHT) pay dividends? If so, how much?
Sight Sciences Inc(SGHT) does not pay dividend.
Guru Commentaries on NAS:SGHT
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers